POET Technologies Appoints David Lazovsky as Executive

New Post Public Reply Private Reply Replies (0) Message Board
sevenOdouble
894
POET Technologies Appoints David Lazovsky as Executive Chairman of Board

February 01, 2017 08:00 ET | Source: POET Technologies Inc.
SAN JOSE, Calif., Feb. 01, 2017 (GLOBE NEWSWIRE) -- POET Technologies Inc. (the “Company” or “POET”) (OTCQX: POETF) (TSX-V: PTK), a developer of opto-electronic fabrication processes for the semiconductor industry, today announced the appointment of David Lazovsky as Executive Chairman of the Board of Directors effective February 1, 2017. Ajit Manocha will remain as a Director on the Board.

David E. Lazovsky has been a member of the POET Board of Directors since April 7, 2015. He is the founder of Intermolecular (NASDAQ:IMI) and served as the company's President and Chief Executive Officer and as a member of the Board of Directors from September 2004 to October 2014. As President and CEO, Lazovsky led all aspects of the business through its lifecycle from early stage start-up to a high-growth public company. He has an in-depth knowledge of the semiconductor industry, technology and markets. Prior to founding Intermolecular, Lazovsky held several senior management positions at Applied Materials. From 1996 through August 2004, he held management positions in the Metal Deposition and Thin Films Product Business Group where he was responsible for managing more than $1 billion in Applied Materials' semiconductor manufacturing equipment business. From 2003 until 2004, Lazovsky managed key strategic accounts in Business Management where he worked closely with leading IC manufacturers to ensure Applied Materials was developing and providing cutting-edge technology solutions. Previously, Lazovsky served as the Technology Program Manager for the Endura 2 Platform, Applied Materials' flagship 300mm metal deposition platform, and he also worked as part of the Metal Deposition Product Business Group. Lazovsky holds a B.S. in mechanical engineering from Ohio University, and as of December 2016, held 45 issued U.S. patents.

Ajit Manocha's 35+ years of executive semiconductor experience has proven invaluable over the past several years in exposing POET to a wide range of potential customers, partners and stakeholders. He has been critical in raising the visibility and public profile of POET’s disruptive new technology. Additionally, Manocha has been instrumental in building an experienced Silicon Valley-centric board with extensive industry experience that continues to offer relevant industry mentorship. His experience and guidance have created opportunities that can continue to be harvested over the coming months and years. When Manocha agreed to take on the Executive Chairman’s role at POET, he committed to a time-limited period to lead the Company to a certain phase of development. The timing of this transition corresponds with that commitment. The Board greatly appreciates Manocha’s significant contributions over the years in helping the Company to navigate multiple early milestones, as well as for his continued support as a Director on POET’s Board.

As POET moves to the next phase beyond its “lab to fab” transition, Lazovsky's entrepreneurial background is expected to become highly valuable in supporting the Company’s growth objectives in the opto-electronic space. His customer management and collaboration experience in the development of new products is also expected to have a positive impact as POET increasingly focuses on commercialization of products in its development pipeline. His business and technical acumen as well as his experience as both a private and public company CEO and director will benefit POET as the company transitions to the next stage of growth.

Grant of Options
The annual compensation for Lazovsky as Executive Chairman of the Board is US$200,000 per annum, inclusive of all Board fees. The Company granted incentive stock options under the Company's stock option plan to Lazovsky, effective February 1, 2017. The grant consists of the right to purchase up to an aggregate of 3,000,000 common shares. All of these options are exercisable at CAD$0.385 per share. The options vest in stages over a period starting on February 1, 2018 and ending February 1, 2021. The options were granted subject to provisions of the Company's stock option plan and are subject to the TSX Venture Exchange policies and applicable securities laws.

The Company also announced the granting of incentive stock options under the Company’s stock option plan to Rajan Rajgopal following his appointment to President and General Manager of DenseLight Semiconductors, a wholly-owned subsidiary of POET Technologies. The grant consists of the right to purchase up to an aggregate of 500,000 common shares and a four year vesting schedule beginning on January 23, 2018. These options are part of, and not in addition to, the options already authorized and disclosed in the Company’s press release dated July 8, 2016, being part of the CEO and Chairman’s Discretionary Pool established as incentives to attract new highly qualified employees. All of these options are exercisable at CAD$0.36 per share. The options were granted subject to provisions of the Company's stock option plan and are subject to the TSX Venture Exchange policies and applicable securities laws.

About POET Technologies Inc.
POET (Planar Opto-Electronic Technology) is a developer of opto-electronics and Photonic fabrication processes and products. Photonics integration is fundamental to increasing functional scaling and lowering the cost of current Photonic solutions. POET believes that its advanced opto-electronics process platform enables substantial improvements in energy efficiency, component cost and size in the production of smart optical components, the engines driving applications ranging from data centers to consumer products to military applications. Silicon Valley-based POET’s patented module-on-a-chip process, which integrates digital, high-speed analog and optical devices on the same chip, is designed to serve as an industry standard for smart optical components. More information may be obtained at www.poet-technologies.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 - Fax: 416-322-5075

Shareholder Contact:
Shelton Group
Brett L. Perry
Leanne K. Sievers
E: sheltonir@sheltongroup.com

http://globenewswire.com/news-release/2017/02....html?ev=1

POET Technologies Inc. (POET) Stock Research Links

POET Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Wingderm USA Expands Its Footprint at 2025 Aesthetic Show

Updated Category News Views 187

Wingderm USA Takes Center Stage at The Aesthetic Show 2025 Wingderm®, an innovative leader in energy-based medical aesthetic technologies, made a significant impact at The Aesthetic Show (TAS) 2025. This event was a pivotal moment in strengthening Wingderm’s position within the U.S. medical aesthetic market. It was held at a renowned venue and brought together medical...

Continue Reading
INVO Bioscience's Strategic Cash Advance Enhances Financial Stability

Updated Category News Views 259

INVO Bioscience Secures Essential Funding INVO Bioscience, Inc. (NASDAQ:INVO), a prominent player in the medical device sector, has recently embarked on a significant financial maneuver to enhance its operational stability. By entering into a Merchant Cash Advance agreement, the company has obtained $265,000, aiming to bolster its working capital and support various...

Continue Reading
FibroGen Secures $160 Million from Sale to AstraZeneca

Updated Category News Views 120

FibroGen Triumphs with Strategic Sale of China Operations FibroGen, Inc. (NASDAQ: FGEN) is making waves in the biopharmaceutical industry with the recent announcement of its agreement to sell its China subsidiary to AstraZeneca for approximately $160 million. This important financial maneuver not only bolsters FibroGen's financial stability but also positions the company...

Continue Reading
Enzoic Teams Up with CIS CyberMarket for Cybersecurity

Updated Category News Views 76

Enzoic Partners with CIS CyberMarket to Strengthen Cybersecurity Enzoic is excited to announce a strategic partnership with CIS CyberMarket, a program designed to enhance the procurement of cybersecurity solutions for various U.S. government entities, nonprofits, and educational institutions. This collaboration aims to provide those organizations with effective,...

Continue Reading
Fosun's Strategic Sale of German Bank Gathers EUR670 Million

Updated Category News Views 589

Fosun International Completes Strategic Sale of HAL Fosun International Limited has successfully finalized the sale of 99.743% of shares in Hauck Aufhäuser Lampe Privatbank AG (HAL), bringing in EUR670 million. This strategic transaction is a significant part of Fosun's ongoing initiatives to optimize its portfolio and focus on core growth sectors. Transforming Private...

Continue Reading